These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. Yin H; Chao L; Chao J J Biol Chem; 2005 Mar; 280(9):8022-30. PubMed ID: 15611141 [TBL] [Abstract][Full Text] [Related]
5. Intermittent hypoxia changes the interaction of the kinin-VEGF system and impairs myocardial angiogenesis in the hypertrophic heart. Visniauskas B; Perry JC; Gomes GN; Nogueira-Pedro A; Paredes-Gamero EJ; Tufik S; Chagas JR Physiol Rep; 2021 May; 9(9):e14863. PubMed ID: 33991464 [TBL] [Abstract][Full Text] [Related]
6. Exercise training inhibits inflammatory cytokines and more than prevents myocardial dysfunction in rats with sustained beta-adrenergic hyperactivity. Serra AJ; Santos MH; Bocalini DS; Antônio EL; Levy RF; Santos AA; Higuchi ML; Silva JA; Magalhães FC; Baraúna VG; Krieger JE; Tucci PJ J Physiol; 2010 Jul; 588(Pt 13):2431-42. PubMed ID: 20442263 [TBL] [Abstract][Full Text] [Related]
7. Effects of exercise training on kinin receptors expression in rats with myocardial infarction. Shen M; Yu M; Li J; Ma L Arch Physiol Biochem; 2017 Oct; 123(4):206-211. PubMed ID: 28330378 [TBL] [Abstract][Full Text] [Related]
8. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation. Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568 [TBL] [Abstract][Full Text] [Related]
9. The protective effect of piperine against isoproterenol-induced inflammation in experimental models of myocardial toxicity. Viswanadha VP; Dhivya V; Beeraka NM; Huang CY; Gavryushova LV; Minyaeva NN; Chubarev VN; Mikhaleva LM; Tarasov VV; Aliev G Eur J Pharmacol; 2020 Oct; 885():173524. PubMed ID: 32882215 [TBL] [Abstract][Full Text] [Related]
10. The kallikrein-kinin system in post-myocardial infarction cardiac remodeling. Wollert KC; Drexler H Am J Cardiol; 1997 Aug; 80(3A):158A-161A. PubMed ID: 9293971 [TBL] [Abstract][Full Text] [Related]
11. Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation. Chao J; Yin H; Gao L; Hagiwara M; Shen B; Yang ZR; Chao L Hypertension; 2008 Oct; 52(4):715-20. PubMed ID: 18768400 [TBL] [Abstract][Full Text] [Related]
13. Deregulation of XBP1 expression contributes to myocardial vascular endothelial growth factor-A expression and angiogenesis during cardiac hypertrophy in vivo. Duan Q; Ni L; Wang P; Chen C; Yang L; Ma B; Gong W; Cai Z; Zou MH; Wang DW Aging Cell; 2016 Aug; 15(4):625-33. PubMed ID: 27133203 [TBL] [Abstract][Full Text] [Related]
14. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues. Nolly H; Miatello R; Damiani MT; Abate CD Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545 [TBL] [Abstract][Full Text] [Related]
15. Kallikrein-kinin in stroke, cardiovascular and renal disease. Chao J; Chao L Exp Physiol; 2005 May; 90(3):291-8. PubMed ID: 15653716 [TBL] [Abstract][Full Text] [Related]
16. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway. Yao YY; Yin H; Shen B; Smith RS; Liu Y; Gao L; Chao L; Chao J Cardiovasc Res; 2008 Dec; 80(3):354-64. PubMed ID: 18689794 [TBL] [Abstract][Full Text] [Related]
17. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Yoshida H; Zhang JJ; Chao L; Chao J Hypertension; 2000 Jan; 35(1 Pt 1):25-31. PubMed ID: 10642270 [TBL] [Abstract][Full Text] [Related]
19. Limb Blood Flow Restriction Plus Mild Aerobic Exercise Training Protects the Heart Against Isoproterenol-Induced Cardiac Injury in Old Rats: Role of GSK-3β. Naderi-Boldaji V; Joukar S; Noorafshan A; Bahreinipour MA Cardiovasc Toxicol; 2019 Jun; 19(3):210-219. PubMed ID: 30406466 [TBL] [Abstract][Full Text] [Related]
20. The kallikrein-kinin pathways in hypertension and diabetes. Sharma JN; Narayanan P Prog Drug Res; 2014; 69():15-36. PubMed ID: 25130038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]